John W. Matthei
Human Resources Officer at ATHENEXPAR
Profile
John W.
Matthei is currently the Vice President-Human Resources at Athenex, Inc. He previously worked as the Executive Vice President-Human Resources at Stericycle, Inc. from 2004 to 2009.
He also held Vice President positions at Pfingsten Partners LLC and Sagent Pharmaceuticals, Inc. Mr. Matthei received his undergraduate degree from Loyola University of Chicago.
John W. Matthei active positions
| Companies | Position | Start |
|---|---|---|
| ATHENEXPAR | Human Resources Officer | 2017-08-31 |
Former positions of John W. Matthei
| Companies | Position | End |
|---|---|---|
| STERICYCLE, INC. | Human Resources Officer | 2008-12-31 |
| SAGENT PHARMACEUTICALS INC | Public Communications Contact | - |
Pfingsten Partners LLC
 Pfingsten Partners LLC Investment ManagersFinance Pfingsten Partners LLC (Pfingsten Partners) is a private equity firm founded in 1989 by Thomas Steven Bagley. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | - |
Training of John W. Matthei
| Loyola University of Chicago | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| STERICYCLE, INC. | Industrial Services |
| Private companies | 3 |
|---|---|
Pfingsten Partners LLC
Pfingsten Partners LLC Investment ManagersFinance Pfingsten Partners LLC (Pfingsten Partners) is a private equity firm founded in 1989 by Thomas Steven Bagley. The firm is headquartered in Chicago, Illinois. | Finance |
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
- Stock Market
- Insiders
- John W. Matthei
